Albumin-beyond fluid replacement in cardiopulmonary bypass surgery: Why, how, and when?

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 18, Issue 3, 2014, Pages 252-259

  Moret, Enrique ^a   Jacob, Matthias W ^b   Ranucci, Marco ^c   Schramko, Alexey A ^d  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Albumin; Cardiopulmonary bypass; Colloid; Crystalloid

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR; GELATIN; HETASTARCH; PLASMA SUBSTITUTE; ALBUMINOID; COLLOID;

BLEEDING; CARDIOPULMONARY BYPASS; FLUID RESUSCITATION; HEART SURGERY; HEMOSTASIS; HUMAN; HYPERVOLEMIA; KIDNEY FAILURE; LUNG EDEMA; MACROMOLECULE; MICROCIRCULATION; NONHUMAN; ONCOTIC PRESSURE; PLASMA VOLUME; REVIEW; SHEAR STRESS; THROMBOCYTE ADHESION; COLLOID; FLUID THERAPY;

ALBUMINS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; COLLOIDS; FLUID THERAPY; HUMANS; MICROCIRCULATION; PLASMA VOLUME;

EID: 84928029181     PISSN: 10892532     EISSN: 19405596     Source Type: Journal    
DOI: 10.1177/1089253214535667     Document Type: Review

References (54)

1. Raghunathan K, Shaw AD, Bagshaw SM. Fluids are drugs: Type, dose and toxicity. Curr Opin Crit Care. 2013;19: 290-298.
2. Shaw A, Raghunathan K. Fluid management in cardiac surgery: colloid or crystalloid? Anesthesiol Clin. 2013;31: 269-280.
3. Mulhollanda JW, Shelton JC, Luo XY. Blood flow and damage by the roller pumps during cardiopulmonary bypass. J Fluids Struct. 2005;20:129-140.
4. Russell JA, Navickis RJ, Wilkes MM. Albumin versus crystalloid for pump priming in cardiac surgery: Meta-analysis of controlled trials. J Cardiothorac Vasc Anesth. 2004;18: 429-437.
5. Brinkman AC, Romijn JW, van Barneveld LJ, et al. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: An ex vivo evaluation using rotation thromboelastometry. J Cardiothorac Vasc Anesth. 2010;24:422-426.
6. Jacob M, Paul O, Mehringer L, et al. Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation. 2009;87:956-965.
7. Zausig YA, Chappell D, Becker BF, et al. The impact of crystalloidal and colloidal infusion preparations on coronary vascular integrity, interstitial oedema and cardiac performance in isolated hearts. Crit Care. 2013;17:R203.
8. Rex S, Scholz M, Weyland A, et al. Intra- And extravascular volume status in patients undergoing mitral valve replacement: crystalloid vs.colloid priming of cardiopulmonary bypass. Eur J Anaesthesiol. 2006;23:1-9.
9. European Medicines Agency. Press Release EMA/349341/2013. Recommendation to suspend marketing authorisations for hydroxyethyl-starch solutions to be re-examined. European Medicines Agency. July 12, 2013.
10. Canet J, Sabate S, Mazo V. Effects of intraoperative colloid administration on outcome in a population-based general surgical cohort: A propensity score analysis. Minerva Anestesiol. 2013;79:891-905.
11. Finfer S. Reappraising the role of albumin for resuscitation. Curr Opin Crit Care. 2013;19:315-320.
12. Schramko A, Suojaranta-Ylinen R, Kuitunen A, et al. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: A prospective randomized trial. Br J Anaesth. 2010;104:691-697.
13. de la Cruz KI, Bakaeen FG, Wang XL, et al. Hypoalbuminemia and long-term survival after coronary artery bypass: A propensity score analysis. Ann Thorac Surg. 2011;91: 671-675.
14. Joorgensen KA, Stoffersen E. Heparin like activity of albumin. Thromb Res. 1979;16:569-574.
15. Jorgensen KA, Stoffersen E. On the inhibitory effect of albumin on platelet aggregation. Thromb Res. 1980;17:13-18.
16. Thyer J, Unal A, Thomas P, et al. Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins. Vox Sang. 2006;91:292-300.
17. Dichtelmuller HO, Biesert L, Fabbrizzi F, et al. Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: A data collection from Plasma Protein Therapeutics Association member companies. Transfusion. 2011;51:1412-1430.
18. Schramko AA. Removal of colloids: evidence- or emotionalbased medicine? Acta Anaesthesiol Scand. 2013;57:809.
19. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896;19:312-326.
20. Langdell RD, Bowersox LW, Weaver RA, Gibson WS. Coagulation properties of canine thoracic-duct lymph. Am J Physiol. 1960;199:626-628.
21. Jacob M, Chappell D, Stoeckelhuber M, et al. Perspectives in microvascular fluid handling: does the distribution of coagulation factors in human myocardium comply with plasma extravasation in venular coronary segments? J Vasc Res. 2011;48:219-226.
22. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097.
23. Adamson RH, Lenz JF, Zhang X, et al. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol. 2004;557:889-907.
24. Jacob M, Bruegger D, Rehm M, et al. The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res. 2007;73:575-586.
25. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Arch. 2000;440:653-666.
26. Becker BF, Chappell D, Jacob M. Endothelial glycocalyx and coronary vascular permeability: The fringe benefit. Basic Res Cardiol. 2010;105:687-701.
27. Jacob M, Chappell D. Reappraising Starling: The physiology of the microcirculation. Curr Opin Crit Care. 2013;19: 282-289.
28. Jacob M, Bruegger D, Rehm M, et al. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology. 2006;104:1223-1231.
29. McCall MM, Blackwell MM, Smyre JT, et al. Fresh frozen plasma in the pediatric pump prime: A prospective, randomized trial. Ann Thorac Surg. 2004;77:983-987.
30. Oliver WC Jr, Beynen FM, Nuttall GA, et al. Blood loss in infants and children for open heart operations: Albumin 5% versus fresh-frozen plasma in the prime. Ann Thorac Surg. 2003;75:1506-1512.
31. Lee JW, Yoo YC, Park HK, et al. Fresh frozen plasma in pump priming for congenital heart surgery: evaluation of effects on postoperative coagulation profiles using a fibrinogen assay and rotational thromboelastometry. Yonsei Med J. 2013;54:752-762.
32. Russell JA, Navickis RJ, Wilkes MM. Albumin versus crystalloid for pump priming in cardiac surgery: Meta-analysis of controlled trials. J Cardiothorac Vasc Anesth. 2004;18: 429-437.
33. Verheij J, van Lingen A, Beishuizen A, et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med. 2006;32: 1030-1038.
34. Jarvela K, Kaukinen S. Hypertonic saline (7.5%) after coronary artery bypass grafting. Eur J Anaesthesiol. 2001;18: 100-107.
35. Davidson IJ. Renal impact of fluid management with colloids: A comparative review. Eur J Anaesthesiol. 2006;23: 721-738.
36. Hecht-Dolnik M, Barkan H, Taharka A, Loftus J. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: A randomized clinical trial. J Thorac Cardiovasc Surg. 2009;138:703-711.
37. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand. 2005;49:373-378.
38. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg. 2006;102:998-1006.
39. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenpera MT. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg. 2004;98:291-297.
40. Winstedt D, Hanna J, Schott U. Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy. Scand J Clin Lab Invest. 2013;73:161-169.
41. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012;144:223-230.
42. Reinhart K, Perner A, Sprung CL, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med. 2012;38:368-383.
43. Sedrakyan A, Gondek K, Paltiel D, Elefteriades JA. Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest. 2003;123:1853-1857.
44. Levin MA, Lin HM, Castillo JG, et al. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation. 2009;120:1664-1671.
45. Myburgh JA, Finfer S, Bellomo R, et al. Hydro xyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901-1911.
46. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: Safety not adequately addressed. Anesth Analg. 2011;112:635-645.
47. Bland JH, Laver MB, Lowenstein E. Vasodilator effect of commercial 5 per cent plasma protein fraction solutions. JAMA. 1973;224:1721-1724.
48. Ellison N, Behar M, MacVaugh H 3rd, Marshall BE. Bradykinin, plasma protein fraction, and hypotension. Ann Thorac Surg 1980;29:15-19.
49. Jacob M, Chappell D, Conzen P, Wilkes MM, Becker BF, Rehm M. Small-volume resuscitation with hyperoncotic albumin: A systematic review of randomized clinical trials. Crit Care. 2008;12:R34.
50. Fritz HG, Brandes H, Bredle DL, et al. Post-operative hypoalbuminaemia and procalcitonin elevation for prediction of outcome in cardiopulmonary bypass surgery. Acta Anaesthesiol Scand. 2003;47:1276-1283.
51. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: A prospective randomized trial. Anesth Analg. 2009;108:30-36.
52. Onorati F, Santarpino G, Renzulli A, et al. Does priming implementation with low-dose albumin reduce postoperative bleeding following cardiopulmonary bypass? Int J Artif Organs. 2003;26:211-216.
53. Perner A, Haase N, Guttormsen AB, et al; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124-134.
54. Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg. 2013;116:35-48.